Cargando…
Biopharmaceutics modeling and simulations : theory, practice, methods, and applications /
A comprehensive introduction to using modeling and simulation programs in drug discovery and development Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation design,...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, N.J. : Chichester :
Wiley-Blackwell ; John Wiley [distributor],
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn805560505 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 120809s2012 nju ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d MHW |d E7B |d YDXCP |d OCLCQ |d EBLCP |d CCO |d OCLCF |d OCLCQ |d COO |d OCLCQ |d COCUF |d VLB |d ZCU |d MERUC |d OCLCQ |d NJR |d U3W |d OCLCQ |d ICG |d INT |d OCLCQ |d DKC |d OCLCQ |d UKAHL |d OCLCQ |d HS0 |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCA |d OCLCL |d OCLCQ | ||
| 020 | |a 9781118354315 |q (electronic bk.) | ||
| 020 | |a 1118354311 |q (electronic bk.) | ||
| 020 | |z 9781118028681 | ||
| 020 | |z 1118028686 | ||
| 020 | |z 9781118188330 |q (cloth) | ||
| 029 | 1 | |a DEBBG |b BV042795261 | |
| 029 | 1 | |a DEBBG |b BV044163444 | |
| 029 | 1 | |a NZ1 |b 14693652 | |
| 029 | 1 | |a ZWZ |b 178867330 | |
| 035 | |a (OCoLC)805560505 | ||
| 050 | 4 | |a RM301.4 |b .S84 2012eb | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.7 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Sugano, Kiyohiko. | |
| 245 | 1 | 0 | |a Biopharmaceutics modeling and simulations : |b theory, practice, methods, and applications / |c Kiyohiko Sugano. |
| 260 | |a Hoboken, N.J. : |b Wiley-Blackwell ; |a Chichester : |b John Wiley [distributor], |c 2012. | ||
| 300 | |a 1 online resource (1 volume) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a A comprehensive introduction to using modeling and simulation programs in drug discovery and development Biopharmaceutical modeling has become integral to the design and development of new drugs. Influencing key aspects of the development process, including drug substance design, formulation design, and toxicological exposure assessment, biopharmaceutical modeling is now seen as the linchpin to a drug's future success. And while there are a number of commercially available software programs for drug modeling, there has not been a single resource guiding pharmaceutical professionals to the ac. | ||
| 505 | 0 | |a Introduction -- Theoretical framework I : solubility -- Theoretical framework II : dissolution -- Theoretical framework III : biological membrane permeation -- Theoretical framework IV : gastrointestinal transit models and integration -- Physiology of gastrointestinal tract and other administration sites in humans and animals -- Drug parameters -- Validation of mechanistic models -- Bioequivalence and biopharmaceutical classification system -- Dose and particle size dependency -- Enabling formulations -- Food effect -- Biopharmaceutical modeling for miscellaneous cases -- Intestinal transporters -- Strategy in drug discovery and development -- Epistemology of biopharmaceutical modeling and good simulation practice. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Biopharmaceutics. | |
| 650 | 0 | |a Computer simulation. | |
| 650 | 0 | |a Digital computer simulation. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Medical personnel. | |
| 650 | 0 | |a Life sciences. | |
| 650 | 0 | |a Physical sciences. | |
| 650 | 0 | |a Methodology. | |
| 650 | 0 | |a Mathematical models. | |
| 650 | 2 | |a Computing Methodologies | |
| 650 | 2 | |a Pharmacology | |
| 650 | 2 | |a Investigative Techniques. | |
| 650 | 2 | |a Technology, Pharmaceutical | |
| 650 | 2 | |a Analytical, Diagnostic and Therapeutic Techniques and Equipment. | |
| 650 | 2 | |a Health Occupations | |
| 650 | 2 | |a Information Science | |
| 650 | 2 | |a Biological Science Disciplines | |
| 650 | 2 | |a Natural Science Disciplines | |
| 650 | 2 | |a Disciplines and Occupations. | |
| 650 | 2 | |a Methods | |
| 650 | 2 | |a Biopharmaceutics | |
| 650 | 2 | |a Models, Theoretical | |
| 650 | 2 | |a Drug Compounding | |
| 650 | 2 | |a Computer Simulation | |
| 650 | 2 | |a Health Workforce. | |
| 650 | 2 | |a Health Personnel | |
| 650 | 6 | |a Biopharmacie. | |
| 650 | 6 | |a Simulation par ordinateur. | |
| 650 | 6 | |a Pharmacologie. | |
| 650 | 6 | |a Techniques pharmaceutiques. | |
| 650 | 6 | |a Personnel médical. | |
| 650 | 6 | |a Sciences de la vie. | |
| 650 | 6 | |a Sciences physiques. | |
| 650 | 6 | |a Méthodologie. | |
| 650 | 6 | |a Modèles mathématiques. | |
| 650 | 7 | |a simulation. |2 aat | |
| 650 | 7 | |a pharmacology. |2 aat | |
| 650 | 7 | |a biological sciences. |2 aat | |
| 650 | 7 | |a physical sciences. |2 aat | |
| 650 | 7 | |a methodology. |2 aat | |
| 650 | 7 | |a mathematical models. |2 aat | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Physical sciences |2 fast | |
| 650 | 7 | |a Pharmacology |2 fast | |
| 650 | 7 | |a Pharmaceutical technology |2 fast | |
| 650 | 7 | |a Methodology |2 fast | |
| 650 | 7 | |a Medical personnel |2 fast | |
| 650 | 7 | |a Mathematical models |2 fast | |
| 650 | 7 | |a Life sciences |2 fast | |
| 650 | 7 | |a Digital computer simulation |2 fast | |
| 650 | 7 | |a Biopharmaceutics |2 fast | |
| 650 | 7 | |a Computer simulation |2 fast | |
| 650 | 7 | |a Health & Biological Sciences. |2 hilcc | |
| 650 | 7 | |a Pharmacy, Therapeutics, & Pharmacology. |2 hilcc | |
| 758 | |i has work: |a Biopharmaceutics modeling and simulations (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGXdYJGP9fvyTxTr36XDFX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Sugano, Kiyohiko. |t Biopharmaceutics modeling and simulations. |d Hoboken, N.J. : Wiley-Blackwell ; Chichester : John Wiley [distributor], 2012 |z 9781118028681 |w (OCoLC)796278081 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=875932 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH24071754 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL875932 | ||
| 938 | |a ebrary |b EBRY |n ebr10583403 | ||
| 938 | |a EBSCOhost |b EBSC |n 471136 | ||
| 938 | |a YBP Library Services |b YANK |n 7598156 | ||
| 938 | |a YBP Library Services |b YANK |n 8582291 | ||
| 938 | |a YBP Library Services |b YANK |n 12672251 | ||
| 994 | |a 92 |b IZTAP | ||